Bupivacaine HCl - CAS 18010-40-7
Catalog number: 18010-40-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H28N2O.HCl
Molecular Weight:
324.89
COA:
Inquire
Targets:
Others
Description:
Bupivacaine HCl binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells, used for treating cardiac arrhythmias.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1. Solid-state NMR studies of pharmaceutical solids in polymer matrices
Joseph W. Lubach • Brian E. Padden • Stephanie L. Winslow • Jonathon S. Salsbury. Anal Bioanal Chem (2004) 378 : 1504–1510
The multiple polymorphic and pseudopolymorphic forms of bupivacaine-HCl that can be generated upon heating or recrystallization are shown in Fig. 3. If bupivacaine HCl is heated at 100 °C for 12 h, the material becomes disordered, as indicated by the increase in the breadth of the lines in the NMR spectrum. However, the material does not become amorphous. Further heating to 170 °C for 12 h produces yet a different spectrum. This spectrum could be composed of either a mixture of two different forms, or there could be two different crystallographically non-equivalent sites in the unit cell. Yet another form can be generated by recrystallization from ethanol. There is a strong possibility that this is an ethanol solvate, as there is a peak at ~60 ppm that is characteristic of ethanol.
2. Different anesthetic agents-soaked sinus packings on pain management after functional endoscopic sinus surgery: which is the most effective?
Suheyl Haytoglu • Gokhan Kuran • Nuray Bayar Muluk • Osman Kursat Arıkan. Eur Arch Otorhinolaryngol (2016) 273:1769–1777
In the present study, we investigated the efficacy of local anesthetics soaked merocel sinus packs after FESS. Topical anesthetics are classified in two groups, amide and ester derivates. Lidocaine, Bupivacaine, Ropivacaine and Prilocaine are the amide group of topical anesthetic. In 5 groups, 2% lidocaine HCl, 0.25 % Bupivacaine HCl, 0.2 % Ropivacaine, 2 % Prilocaine and 0.9 % NaCl (Saline) were applied, respectively. In our study, preoperative Lund–Mackay CT Score values of the groups were not different. There was no significant difference between bleeding grade of the groups. In Bupivacaine group, number of gauze/24 h use was lower than lidocaine, ropivacaine and prilocaine groups. In saline group, number of gauze/24 h use was higher than lidocaine, ropivacaine and prilocaine groups.
3. The effect of bupivacaine•HCl on the physical properties of neuronal membranes
K. I. Koo & J. H. Bae & C. H. Lee & C. D. Yoon & J. H. Pyun & S. H. Shin & Y. C. Jeon & M. K. Bae. Protoplasma (2008) 234:3–12
Figure 5 shows that the anisotropy (r) of DPH in the TNBS untreated membrane (inner plus outer monolayers) decreased gradually (fluidization) with increasing bupivacaine HCl concentrations (Fig. 5, filled squares). There was a similar, but more gradual, decrease in the calculated anisotropy of the inner monolayer at any bupivacaine•HCl concentration (Fig. 5, filled triangles). The anisotropy of DPH in SPMVs inner monolayer incubated with 1 mM bupivacaine HCl was 0.182±0.005** (n=5, P<0.01), and the change in anisotropy value before and after adding 1 mM bupivacaine•HCl was 0.038. The values in the inner monolayer were 0.220±0.003 (n=5) and 0.269±0.005 (n=5) at 37°C and 25°C, respectively. Thus the effect of 1 mM bupivacaine HCl was equivalent to that produced by a temperature increase of approximate 9.3°C. However, there was no statistically significant decrease in the anisotropy (the rotational mobility range) of the outer monolayer at 0.01∼0.02 mM of the bupivacaine•HCl concentrations used. These results suggest that the fluidizing effect (range of rotational mobility) of bupivacaine•HCl is selective.
4. Controlled release of bupivacaine HCl through microchannels of biodegradable drug delivery device
Kang Ju Lee & Sung Yeun Yang & WonHyoung Ryu. Biomed Microdevices (2012) 14:583–593
Release of bupivacaine HCl in deionized water and phosphate buffered saline solution To assess the effect of release media, microfluidic devices containing BHCl were tested in both deionized water (DI water) and phosphate buffered saline (PBS) solutions. Two groups of devices were fabricated to have the channel lengths of 0.7 mm and one group of devices had the release channels of 1.6 mm. The amount of bupivacaine loaded in each device (2.4 mg/device on average)was determined such that the solubility limit of the analgesic was maintained over three days. Under this condition, diffusional transport of BHCl was expected to be at a constant rate for at least three days. As shown in Fig. 4, when devices with 0.7 mm long channels were placed in DI water, BHCl was released at a constant rate close to the estimated value from Table 1. However, devices with the same channel lengths (0.7 mm) was tested in a PBS solution, the release profile showed biphasic patterns. Until day one, it showed zero-order release almost identical to the devices in DI water.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 537-12-2 Diperodon hydrochloride

Diperodon hydrochloride
(CAS: 537-12-2)

Diperodon hydrochloride is a local anaesthetics designated by chemical abstracts as 3-piperidino-1,2-propanediol dicarbanilate monohydrate.

CAS 57248-88-1 Pamidronate Disodium

Pamidronate Disodium
(CAS: 57248-88-1)

Pamidronic acid (INN) or pamidronate disodium (USAN), pamidronate disodium pentahydrate is a nitrogen-containingbisphosphonate, used to prevent osteoporosis.

CAS 1152782-19-8 A 1120

A 1120
(CAS: 1152782-19-8)

A 1120 is a retinol-binding protein 4 (RBP4) antagonist (Ki = 8.3 nM) that can reduce serum RBP4 and retinol, and displaces transthyretin (TTR) from RBP4-TTR co...

DAA-1106
(CAS: 220551-92-8)

DAA-1106, with anxiolytic effects in mice, is a selective ligand for peripheral benzodiazepine receptor (PBR) and a selective agonist at the peripheral benzodia...

CAS 222030-63-9 Fosbretabulin

Fosbretabulin
(CAS: 222030-63-9)

Fosbretabulin, also called as CA4P, has antitumor activity against anaplastic thyroid cancer (ATC) cell lines. Fosbretabulin, a novel water-soluble vascular-dis...

GI 181771
(CAS: 305366-98-7)

GI-181771X is a novel effect of oral CCK-1 agonist on fasting and postprandial gastric functions in healthy volunteers.

CAS 38260-01-4 Triethylenetetramine Dihydrochloride

Triethylenetetramine Dihydrochloride
(CAS: 38260-01-4)

Triethylenetetramine Hydrochloride is a selective CuII-chelator, undergoing trials for the treatment of heart failure in patients with diabetes.

CH 141
(CAS: 78279-88-6)

CH 141 is a peripheral vasodilator.

CAS 76822-21-4 Danshensu

Danshensu
(CAS: 76822-21-4)

Danshensu is an active component of Salvia miltiorrhiza that shows wide cardiovascular benefit. It suppresses the formation of reactive oxygen species and inhib...

CB-3988
(CAS: 112888-26-3)

CB 3988 is a bio-active chemical compound.

CHEMBL2426474
(CAS: 1418741-86-2)

CHEMBL2426474, also called as UNC1079, the piperidine analog of UNC1021 that has binding affinity to L3MBTL3 in human G401 cells by Western blot based pulldown ...

CAS 61714-25-8 W-5 hydrochloride

W-5 hydrochloride
(CAS: 61714-25-8)

W-5 hydrochloride is a calmodulin antagonist that inhibits Ca2+-calmodulin dependent PDE with an IC50 of 240 μM.

CAS 1796596-46-7 NSC 23005 sodium

NSC 23005 sodium
(CAS: 1796596-46-7)

NSC23005 sodium is a p18INK inhibitor. It can promote hematopoietic stem cell expansion with ED50 of 5.21 nM.

CAS 100929-71-3 β-NADPH tetra (cyclohexylammonium) salt

β-NADPH tetra (cyclohexylammonium) salt
(CAS: 100929-71-3)

β-NADPH tetra(cyclohexylammonium), generating in vivio by the pentose phosphate pathway, is a a ubiquitous cofactor and biological reducing agent.

CAS 13721-39-6 Sodium orthovanadate

Sodium orthovanadate
(CAS: 13721-39-6)

Sodium orthovanadate is an alkaline phosphatase and (Na,K)-ATPase inhibitor with IC50 of 10 μM.

CAS 3685-84-5 Meclofenoxate hydrochloride

Meclofenoxate hydrochloride
(CAS: 3685-84-5)

Meclofenoxate (Lucidril), also known as centrophenoxine, is a drug used to treat the symptoms of senile dementia and Alzheimer's disease. It is an ester of dime...

BAY-721973
(CAS: 1380310-94-0)

BAY-721973 is a bio-active chemical,but few detailed information has been published yet.

CAS 491-70-3 Luteolin

Luteolin
(CAS: 491-70-3)

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor.

CAS 3819-00-9 Piperacetazine

Piperacetazine
(CAS: 3819-00-9)

Piperacetazine is an antipsychotic drug, most notably used for schizophrenia

CAS 1509-34-8 L-Allo-isoleucine

L-Allo-isoleucine
(CAS: 1509-34-8)

L-Allo-isoleucine, an amino acid compound, has been found to be probably significant in the study of modulating of blood sugar.

Chemical Structure

CAS 18010-40-7 Bupivacaine HCl

Quick Inquiry

Verification code

Featured Items